We hereby inform you that the timing of the earnings conference call to discuss the financial results for the second quarter of FY 2026-27 (Q2 FY27) has been re-scheduled to 04:00 P.M. (IST) from 05:00 P.M. (IST) on Thursday, October 29, 2026

Date: October 23, 2026 To, To, Sr. General Manager Sr. General Manager Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street Bandra Kurla Complex Mumbai – 400 001 Bandra (E), Mumbai – 400 051 BSE Scrip Code: 544319 NSE Symbol: SENORES Sub.: Re‐scheduling of Timing of Earnings Conference Call for Q2 FY 2026‐27 Dear Sir/Ma’am, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in continuation of our earlier intimation dated October 22, 2026, we hereby inform you that the timing of the earnings conference call to discuss the financial results for the second quarter of FY 2026-27 (Q2 FY27) has been rescheduled to 04:00 P.M. (IST) from 05:00 P.M. (IST) on Thursday, October 29, 2026. The details of the aforesaid revised earnings conference call is annexed herewith. The audio recording and transcript of the aforesaid call will be subsequently published on the website of the Company and will be intimated accordingly. You are requested to take the same on record. Thanking you. For Senores Pharmaceuticals Limited Shilpa Sharma Company Secretary & Compliance Officer Membership Number: A34516 Enclosures: As above Senores Pharmaceuticals Limited 1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park, Ambali Bopal Road, Ahmedabad‐380054, Gujarat, India P: +91 79 2999 9857 | E: info@senorespharma.com W: www.senorespharma.com | CIN No.: L24290GJ2017PLC100263 Senores Pharmaceuticals Ltd Q2 & H1 FY27 Earnings Call Thursday, 29 October 2026 at 16:00 hrs (IST) DAM Capital Advisors Ltd invites you to Senores Pharmaceuticals Ltd’s post results conference call Senores Pharmaceuticals Ltd’s Management Speakers Mr. Swapnil Shah – Promoter and Managing Director Mr. Sanjay Majmudar – Chairman Mr. Deval Shah – Whole Time Director and Chief Financial Officer Call Leaders Nitin Agarwal – Analyst, DAM Capital Advisors Ltd Dial-in Details Universal access: +91 22 6280 1384, +91 22 7115 8285 (accessible from all networks and countries) Diamond passcode link: click here International dial-in Hong Kong Singapore UK USA 18:30 (HKT) 18:30 (SGT) 11:30 (BST) 06:30 (EDT) Toll free 800964448 8001012045 08081011573 18667462133 *Please dial-in at least 5-10 minutes prior to the schedule to get connected to the call in time For further information please contact Nitin Agarwal / Payal Shah DAM Capital Advisors Limited : +91 22 4202 2568 / 2638  nitin.a@damcapital.in / payal@damcapital.in